Michał Leśkiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michał Leśkiewicz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Justyna Składanek
Doctor Anna Gostyńska Wolski Hospital, Marcina Kasprzaka 17, 01-211 Warsaw
9 shared publications - Joanna Cieszkowska
Uniwersytet Medyczny w Lublinie
8 shared publications - Karina Otręba
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
7 shared publications - Karolina Czupryńska
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
7 shared publications - Piotr Daniel
National Medical Institute of the Ministry of the Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland
7 shared publications - Barbara Kopczyńska
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
2 shared publications
Latest Publications
- Open Access
- 13 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55013
Therapeutic potential of curcuminoids in the treatment of selected autoimmune diseases
Introduction The cause of autoimmune diseases is often unknown. Continuous research into the mechanism of these diseases allows us to discover new metabolic pathways, and thus new potential drugs that may become promising therapeutic tools in the future. Alternative methods of treatment are increasingly used when standard therapy does not bring the intended effects. One of the alternative methods of treatment is turmeric contained in Curcuma longa L. Aim of the study The aim of this article was to present the extremely promising potential of turmeric in the treatment of autoimmune diseases. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results In recent years, research on turmeric has accelerated significantly. Due to the insufficient effects of therapy achieved with standard methods of treatment, researchers want to find a new agent to fight serious diseases. Currently available medical literature has confirmed the beneficial effects of turmeric on inflammation in the body. The very mild side effect profile is also worth noting. Conclusions The anti-inflammatory effect obtained after the administration of appropriate doses of turmeric requires further research before it can be registered as one of the preparations for the treatment of autoimmune diseases. However, this topic is very interesting, and the substance itself is very interesting in the context of future disease therapy.
- 13 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55013
Open AccessTherapeutic potential of curcuminoids in the treatment of selected autoimmune diseases
Introduction The cause of autoimmune diseases is often unknown. Continuous research into the mechanism of these diseases allows us to discover new metabolic pathways, and thus new potential drugs that may become promising therapeutic tools in the future. Alternative methods of treatment are increasingly used when standard therapy does not bring the intended effects. One of the alternative methods of treatment is turmeric contained in Curcuma longa L. Aim of the study The aim of this article was to present the extremely promising potential of turmeric in the treatment of autoimmune diseases. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results In recent years, research on turmeric has accelerated significantly. Due to the insufficient effects of therapy achieved with standard methods of treatment, researchers want to find a new agent to fight serious diseases. Currently available medical literature has confirmed the beneficial effects of turmeric on inflammation in the body. The very mild side effect profile is also worth noting. Conclusions The anti-inflammatory effect obtained after the administration of appropriate doses of turmeric requires further research before it can be registered as one of the preparations for the treatment of autoimmune diseases. However, this topic is very interesting, and the substance itself is very interesting in the context of future disease therapy.
- Open Access
- 9 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 54495
Efficacy and Controversies Surrounding Electroconvulsive Therapy for Treatment-Resistant Depression: A Literature Review
Electroconvulsive therapy (ECT) remains a vital treatment option for individuals with treatment-resistant depression (TRD). Despite its historical stigma, controversy, and limited accessibility, ECT has been demonstrated to be beneficial and effective in severe cases of depressive disorders, where medication fails to produce results. It has been utilized since 1938 as a therapeutic technique for various psychiatric disorders, often used as an alternative to chemically induced seizures. The public’s perspectives on ECT hold significance as they can shape attitudes toward patients undergoing this therapy and the discrimination associated with receiving ECT. Additionally, the perspectives of patients who may benefit from ECT and those who are already undergoing treatment are crucial as they can influence treatment decisions and consent processes. This literature review examines the efficacy and controversies surrounding ECT in the management of TRD. Studies assessing the effectiveness of ECT in TRD, along with associated adverse effects and ethical considerations, are reviewed. Additionally, the role of ECT in contemporary psychiatric practice and its comparison with alternative treatments for TRD are discussed. The review highlights the complex interplay between clinical efficacy, safety, patient preferences, and societal perceptions in shaping the utilization of ECT in the treatment of TRD.
- 9 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 54495
Open AccessEfficacy and Controversies Surrounding Electroconvulsive Therapy for Treatment-Resistant Depression: A Literature Review
Electroconvulsive therapy (ECT) remains a vital treatment option for individuals with treatment-resistant depression (TRD). Despite its historical stigma, controversy, and limited accessibility, ECT has been demonstrated to be beneficial and effective in severe cases of depressive disorders, where medication fails to produce results. It has been utilized since 1938 as a therapeutic technique for various psychiatric disorders, often used as an alternative to chemically induced seizures. The public’s perspectives on ECT hold significance as they can shape attitudes toward patients undergoing this therapy and the discrimination associated with receiving ECT. Additionally, the perspectives of patients who may benefit from ECT and those who are already undergoing treatment are crucial as they can influence treatment decisions and consent processes. This literature review examines the efficacy and controversies surrounding ECT in the management of TRD. Studies assessing the effectiveness of ECT in TRD, along with associated adverse effects and ethical considerations, are reviewed. Additionally, the role of ECT in contemporary psychiatric practice and its comparison with alternative treatments for TRD are discussed. The review highlights the complex interplay between clinical efficacy, safety, patient preferences, and societal perceptions in shaping the utilization of ECT in the treatment of TRD.
- Open Access
- 1 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 54255
Various aspects of the doctor's quality of life
Nowadays, more and more attention is paid to the quality of life. Both private and work-related. More and more actions are taken to improve the quality of life in order to reduce the phenomenon of professional burnout. This significantly improves work efficiency and allows employees to work longer. It is no different in medical professions, including doctors. Fortunately, there is more and more scientific research on this topic. This allowed us to write an illustrative article about various aspects of the doctor's quality of life. The article will provide information about what quality of life really is and how it is defined. We will present the impact of various factors influencing this, such as length of work, sleep time, age, shift work and work at irregular intervals. We will also show how occupational factors influence health, which translates quite well into life expectancy. It is surprising that doctors have higher than expected risk factors for cardiovascular diseases such as hypertension, hypercholesterolemia, body mass. The cause is usually high stress and lack of time for physical activities after work. Specialization is also important when it comes to life expectancy. Charts with this information about expected age will be presented along with discussion in the text. We hope that in the future there will be further research expanding knowledge on this very important topic. And employers will have developed appropriate standards to improve the quality of life among their employees.
- 1 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 54255
Open AccessVarious aspects of the doctor's quality of life
Nowadays, more and more attention is paid to the quality of life. Both private and work-related. More and more actions are taken to improve the quality of life in order to reduce the phenomenon of professional burnout. This significantly improves work efficiency and allows employees to work longer. It is no different in medical professions, including doctors. Fortunately, there is more and more scientific research on this topic. This allowed us to write an illustrative article about various aspects of the doctor's quality of life. The article will provide information about what quality of life really is and how it is defined. We will present the impact of various factors influencing this, such as length of work, sleep time, age, shift work and work at irregular intervals. We will also show how occupational factors influence health, which translates quite well into life expectancy. It is surprising that doctors have higher than expected risk factors for cardiovascular diseases such as hypertension, hypercholesterolemia, body mass. The cause is usually high stress and lack of time for physical activities after work. Specialization is also important when it comes to life expectancy. Charts with this information about expected age will be presented along with discussion in the text. We hope that in the future there will be further research expanding knowledge on this very important topic. And employers will have developed appropriate standards to improve the quality of life among their employees.
- Open Access
- 1 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 54210
Bergamot extract and red yeast rice in reducing high cholesterol - what is known?
Obtaining optimal levels of lipoproteins and total cholesterol is one of the main goals for reducing cardiovascular risk. Many patients insist on changing their statin treatment to a nutraceutical such as Bergamot extract or red yeast rice extract, due to statin intolerance affecting some of them and increasing disinformation on statin side effects. This is why, interest in lipid-lowering ability of available nutraceuticals, is growing. In our work, we tried to summarise what is known about nutraceuticals such as red yeast rice and bergamot extract and how they can be used in clinical practise. We searched two databases such us Pubmed and Medline byusing the terms “bergamot”, ”red yeast rice”, “dyslipidaemia” and “hypercholesterolaemia” Products containing red yeast rice and bergamot extract are dietary supplements which are sold over the counter. There is possibility that they can be seen as natural substances which significantly reduce cholesterol levels, however, they have weaker effect than strong statins. They cannot be replacement for them. Red yeast rice is the leading substance. It can be used in patients with moderate hypercholesterolemia or can be combined with ezetimibe if statins are badly tolerated. There is no clear opinion of experts on bergamot due to lack of larger and longer studies. As our article show it is crucial to conduct more scientific research on nutraceuticals especially Bergamot extract.
- 1 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 54210
Open AccessBergamot extract and red yeast rice in reducing high cholesterol - what is known?
Obtaining optimal levels of lipoproteins and total cholesterol is one of the main goals for reducing cardiovascular risk. Many patients insist on changing their statin treatment to a nutraceutical such as Bergamot extract or red yeast rice extract, due to statin intolerance affecting some of them and increasing disinformation on statin side effects. This is why, interest in lipid-lowering ability of available nutraceuticals, is growing. In our work, we tried to summarise what is known about nutraceuticals such as red yeast rice and bergamot extract and how they can be used in clinical practise. We searched two databases such us Pubmed and Medline byusing the terms “bergamot”, ”red yeast rice”, “dyslipidaemia” and “hypercholesterolaemia” Products containing red yeast rice and bergamot extract are dietary supplements which are sold over the counter. There is possibility that they can be seen as natural substances which significantly reduce cholesterol levels, however, they have weaker effect than strong statins. They cannot be replacement for them. Red yeast rice is the leading substance. It can be used in patients with moderate hypercholesterolemia or can be combined with ezetimibe if statins are badly tolerated. There is no clear opinion of experts on bergamot due to lack of larger and longer studies. As our article show it is crucial to conduct more scientific research on nutraceuticals especially Bergamot extract.
- Open Access
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51720
Symptoms and prophylaxis of venous thromboembolism in the population of cancer and hospice patients-what is known?
In a group of palliative patients, venous thromboembolism (VTE) is a significant cause of death and reduction in quality of life. Current guidelines and scientific research on thromboprophylaxis most often refer to the population of oncology patients, who differ in many aspects from patients receiving palliative care. Thus, doctors working with patients undergoing palliative treatment have to face many problems related to safety and effectiveness of antithrombotic therapy in this type of care. In the case of chronically ill patients, diagnostic process may be somewhat difficult because the symptoms resulting from the underlying diseases can mask VTE symptoms. The aim of this article is to review the literature on symptoms and thromboprophylaxis in this group of patients. According to the latest guidelines of the American Society of Clinical Oncology (ASCO), it is not recommended to use VTE prophylaxis in outpatient oncology patients routinely, but it should be considered in high-risk patients who received a Khorana score of at least 2 before starting a new chemotherapy cycle. In patients diagnosed with VTE, in long-term prophylaxis lasting at least 6 months, due to greater effectiveness, it is recommended to use low-molecular-weight heparins, edoxaban, rivaroxaban or apixaban instead of vitamin K antagonists, which can be used if the previously mentioned drugs are unavailable. There are some studies which show that thromboprophylaxis may be beneficial for patients in palliative care. On the other hand, another studies’ results suggest that patients won’t gain any benefit from prevention. As our article shows it is very crucial to conduct scientific research on palliative patients and create clear guidelines for prophylaxis for this group of people.
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51720
Open AccessSymptoms and prophylaxis of venous thromboembolism in the population of cancer and hospice patients-what is known?
In a group of palliative patients, venous thromboembolism (VTE) is a significant cause of death and reduction in quality of life. Current guidelines and scientific research on thromboprophylaxis most often refer to the population of oncology patients, who differ in many aspects from patients receiving palliative care. Thus, doctors working with patients undergoing palliative treatment have to face many problems related to safety and effectiveness of antithrombotic therapy in this type of care. In the case of chronically ill patients, diagnostic process may be somewhat difficult because the symptoms resulting from the underlying diseases can mask VTE symptoms. The aim of this article is to review the literature on symptoms and thromboprophylaxis in this group of patients. According to the latest guidelines of the American Society of Clinical Oncology (ASCO), it is not recommended to use VTE prophylaxis in outpatient oncology patients routinely, but it should be considered in high-risk patients who received a Khorana score of at least 2 before starting a new chemotherapy cycle. In patients diagnosed with VTE, in long-term prophylaxis lasting at least 6 months, due to greater effectiveness, it is recommended to use low-molecular-weight heparins, edoxaban, rivaroxaban or apixaban instead of vitamin K antagonists, which can be used if the previously mentioned drugs are unavailable. There are some studies which show that thromboprophylaxis may be beneficial for patients in palliative care. On the other hand, another studies’ results suggest that patients won’t gain any benefit from prevention. As our article shows it is very crucial to conduct scientific research on palliative patients and create clear guidelines for prophylaxis for this group of people.
- Open Access
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51722
Diagnosis and treatment of migraine: an analysis of the latest diagnostic and therapeutic guidelines
Introduction Migraine is a common disease that a large part of the population struggles with. Stressful work and poor eating habits increase the risk of headaches. The basic therapy is lifestyle change, and when this does not bring results, medications are used. The choice of the appropriate preparation depends on the characteristics of the pain and the patient's condition. Knowledge about different treatment methods can improve patients' lives. Aim of the study The aim of the article was to present current guidelines for migraine therapy depending on the individual patient's requirements. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results Many clinical trials have examined the effects of different classes of drugs on migraine headaches. The final effect depends on the dose used, the moment of drug administration, and the patient's age, gender and health condition. Doctors often have to modify therapy within the same group of drugs to find a drug that will work for a given patient. Conclusions Clinical trials have proven the effectiveness of, among others, non-steroidal anti-inflammatory drugs, triptans and botulinum neurotoxin. A clinically significant analgesic effect is sometimes characterized by side effects, therefore careful selection of the preparation and patient observation are important.
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51722
Open AccessDiagnosis and treatment of migraine: an analysis of the latest diagnostic and therapeutic guidelines
Introduction Migraine is a common disease that a large part of the population struggles with. Stressful work and poor eating habits increase the risk of headaches. The basic therapy is lifestyle change, and when this does not bring results, medications are used. The choice of the appropriate preparation depends on the characteristics of the pain and the patient's condition. Knowledge about different treatment methods can improve patients' lives. Aim of the study The aim of the article was to present current guidelines for migraine therapy depending on the individual patient's requirements. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results Many clinical trials have examined the effects of different classes of drugs on migraine headaches. The final effect depends on the dose used, the moment of drug administration, and the patient's age, gender and health condition. Doctors often have to modify therapy within the same group of drugs to find a drug that will work for a given patient. Conclusions Clinical trials have proven the effectiveness of, among others, non-steroidal anti-inflammatory drugs, triptans and botulinum neurotoxin. A clinically significant analgesic effect is sometimes characterized by side effects, therefore careful selection of the preparation and patient observation are important.
- Open Access
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51716
Intraductal Papillary Mucinous Neoplasms (IPMN): Diagnosis, Classification, and Risk Assessment - A Review of Current Medical Knowledge
Introduction In recent years, the widespread utilisation of advanced imaging modalities has led to a surge in the detection rate of pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasms (IPMN). Consequently, this review aims to provide a comprehensive examination of IPMN, focusing on elucidating its intricate facets including definition, epidemiology, pathogenesis, classification, imaging modalities for diagnosis, analysis of pancreatic cyst fluid, evaluation of malignant potential, and identification of pertinent features. Brief Overview of Current Knowledge: IPMN represents a diagnostic conundrum owing to its variable biological behaviour encompassing both benign and malignant spectra, necessitating meticulous evaluation and risk stratification. Various imaging techniques such as MRI, CT, EUS and abdominal ultrasonography serve pivotal roles in the diagnostic algorithm and risk assessment of IPMN. Additionally, the analysis of pancreatic cyst fluid, incorporating biomarkers and the string sign test, assumes a critical role in discerning mucinous from non-mucinous cysts and gauging malignant potential. Discriminating high-risk stigmata and worrisome features serve as a compass for clinical decision-making regarding the imperative of surgical intervention versus vigilant surveillance. Summary Despite persistent challenges, the ongoing evolution of diagnostic modalities and risk assessment methodologies augur well for refining therapeutic strategies and enhancing clinical outcomes in managing IPMN. This review underscores the imperative of sustained research endeavours in the realm of pancreatic oncology to enrich our comprehension of IPMN pathophysiology and to optimise clinical care paradigms.
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51716
Open AccessIntraductal Papillary Mucinous Neoplasms (IPMN): Diagnosis, Classification, and Risk Assessment - A Review of Current Medical Knowledge
Introduction In recent years, the widespread utilisation of advanced imaging modalities has led to a surge in the detection rate of pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasms (IPMN). Consequently, this review aims to provide a comprehensive examination of IPMN, focusing on elucidating its intricate facets including definition, epidemiology, pathogenesis, classification, imaging modalities for diagnosis, analysis of pancreatic cyst fluid, evaluation of malignant potential, and identification of pertinent features. Brief Overview of Current Knowledge: IPMN represents a diagnostic conundrum owing to its variable biological behaviour encompassing both benign and malignant spectra, necessitating meticulous evaluation and risk stratification. Various imaging techniques such as MRI, CT, EUS and abdominal ultrasonography serve pivotal roles in the diagnostic algorithm and risk assessment of IPMN. Additionally, the analysis of pancreatic cyst fluid, incorporating biomarkers and the string sign test, assumes a critical role in discerning mucinous from non-mucinous cysts and gauging malignant potential. Discriminating high-risk stigmata and worrisome features serve as a compass for clinical decision-making regarding the imperative of surgical intervention versus vigilant surveillance. Summary Despite persistent challenges, the ongoing evolution of diagnostic modalities and risk assessment methodologies augur well for refining therapeutic strategies and enhancing clinical outcomes in managing IPMN. This review underscores the imperative of sustained research endeavours in the realm of pancreatic oncology to enrich our comprehension of IPMN pathophysiology and to optimise clinical care paradigms.
- Open Access
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51721
Why is surgery not popular among medical students and young doctors? - Review of literature
Introduction: Contemporary medicine is witnessing significant advancements in conservative treatment modalities. However, surgery remains paramount for radical cancer treatment and emergent conditions such as trauma, peritonitis, gastrointestinal obstruction, and cholecystitis. Despite the essential role of surgeons, there is a global trend indicating waning interest among medical students in pursuing surgical specialties. Concurrently, practicing surgeons report heightened levels of professional burnout, and many regions face a looming shortage of surgical professionals, posing a threat to healthcare quality. Brief Overview of Current Knowledge: Research conducted across Poland, Germany, Argentina, the United Kingdom, and Japan highlights the declining inclination towards surgery among medical students. Students cite unattractive working conditions, poor work-life balance, elevated stress levels, and limited avenues for scholarly growth as deterrents. Gender plays a role, with females expressing heightened concerns regarding work-life balance and family aspirations. Furthermore, the surgical work environment, inadequate preparatory training in medical schools, and prolonged working hours are identified as factors exacerbating burnout risk among surgeons. Summary: Professional burnout represents a significant concern among surgeons, impacting both their work satisfaction and patient safety. Despite the strides made in conservative medical therapies, surgery remains indispensable, yet its allure as a specialty is diminishing among medical students. Understanding and addressing the discouraging factors, along with promoting healthy work practices, may mitigate burnout and encourage young physicians to consider surgical careers.
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51721
Open AccessWhy is surgery not popular among medical students and young doctors? - Review of literature
Introduction: Contemporary medicine is witnessing significant advancements in conservative treatment modalities. However, surgery remains paramount for radical cancer treatment and emergent conditions such as trauma, peritonitis, gastrointestinal obstruction, and cholecystitis. Despite the essential role of surgeons, there is a global trend indicating waning interest among medical students in pursuing surgical specialties. Concurrently, practicing surgeons report heightened levels of professional burnout, and many regions face a looming shortage of surgical professionals, posing a threat to healthcare quality. Brief Overview of Current Knowledge: Research conducted across Poland, Germany, Argentina, the United Kingdom, and Japan highlights the declining inclination towards surgery among medical students. Students cite unattractive working conditions, poor work-life balance, elevated stress levels, and limited avenues for scholarly growth as deterrents. Gender plays a role, with females expressing heightened concerns regarding work-life balance and family aspirations. Furthermore, the surgical work environment, inadequate preparatory training in medical schools, and prolonged working hours are identified as factors exacerbating burnout risk among surgeons. Summary: Professional burnout represents a significant concern among surgeons, impacting both their work satisfaction and patient safety. Despite the strides made in conservative medical therapies, surgery remains indispensable, yet its allure as a specialty is diminishing among medical students. Understanding and addressing the discouraging factors, along with promoting healthy work practices, may mitigate burnout and encourage young physicians to consider surgical careers.
- Open Access
- 26 May 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 72, 51119
Risk Factors for Thromboembolism in the Population of Cancer and Hospice Patients
Venous thromboembolism (VTE) is a significant cause of death among palliatively treated patients. So far, numerous studies have been conducted on the general population. As a result, special scales were created to assess the risk of VTE or the probability of its occurrence. Among patients with terminal disease, there are much fewer publications discussing the problem of VTE. Hospice care patients constitute a special group due to their epidemiological structure and accompanying diagnoses. The most common are malignant tumors and heart failure. For this reason, they are particularly vulnerable to VTE events. This article reviews the literature on risk scales such as The Padua Risk Assessment Scale, Khoran score, Wells scale, PVFS scale and VTE-BLEED scale. W also present risk factors which contribute to the development of the VTE as well as to a more serious course of VTE. We discuss the epidemiological structure of patients, the impact of cancer as well as the chemotherapy used to treat it. We discuss the epidemiological structure of patients, the impact of cancer as well as the chemotherapy used in its treatment. We describe how the presence of a catheter and immobilization contribute to the development of VTE. We focus particularly on scales and risk factors to which a patient with a terminal disease is exposed. More research is needed in the future to better predict VTE in hospice patients. We hope that this work will increase awareness and encourage researchers to expand knowledge in this area.
- 26 May 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 72, 51119
Open AccessRisk Factors for Thromboembolism in the Population of Cancer and Hospice Patients
Venous thromboembolism (VTE) is a significant cause of death among palliatively treated patients. So far, numerous studies have been conducted on the general population. As a result, special scales were created to assess the risk of VTE or the probability of its occurrence. Among patients with terminal disease, there are much fewer publications discussing the problem of VTE. Hospice care patients constitute a special group due to their epidemiological structure and accompanying diagnoses. The most common are malignant tumors and heart failure. For this reason, they are particularly vulnerable to VTE events. This article reviews the literature on risk scales such as The Padua Risk Assessment Scale, Khoran score, Wells scale, PVFS scale and VTE-BLEED scale. W also present risk factors which contribute to the development of the VTE as well as to a more serious course of VTE. We discuss the epidemiological structure of patients, the impact of cancer as well as the chemotherapy used to treat it. We discuss the epidemiological structure of patients, the impact of cancer as well as the chemotherapy used in its treatment. We describe how the presence of a catheter and immobilization contribute to the development of VTE. We focus particularly on scales and risk factors to which a patient with a terminal disease is exposed. More research is needed in the future to better predict VTE in hospice patients. We hope that this work will increase awareness and encourage researchers to expand knowledge in this area.